FDA approves first treatment for thyroid eye disease
eMediNexus, 22 January 2020
remove_red_eye 651 Views
#Diabetes and Endocrinology #Infectious Diseases #Ophthalmology #Pharmacist
Coronavirus Live Count Map India
remove_red_eye 651 Views
COVID-19 Vaccine Updates
#Diabetes and Endocrinology #Infectious Diseases #Ophthalmology #Pharmacist
The U.S. Food and Drug Administration (FDA) has approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis). The approval represents the first drug approved for the treatment of thyroid eye disease… (FDA, January 21, 2020)
To comment on this article,
create a free account.
Sign Up
to instantly read 30000+ free Articles & 1000+ Case Studies
Already registered?
.jpg)
